Carol Pollock
Carol Pollock
Professor of Medicine University of Sydney
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
ADVANCE Collaborative Group
New England journal of medicine 358 (24), 2560-2572, 2008
87692008
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England Journal of Medicine 380 (24), 2295-2306, 2019
22322019
A randomized, controlled trial of early versus late initiation of dialysis
BA Cooper, P Branley, L Bulfone, JF Collins, JC Craig, MB Fraenkel, ...
New England Journal of Medicine 363 (7), 609-619, 2010
8462010
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ...
The Lancet 390 (10105), 1888-1917, 2017
5372017
The influence of dialysis treatment modality on the decline of remaining renal function.
MJ Lysaght, EF Vonesh, F Gotch, L Ibels, M Keen, B Lindholm, KD Nolph, ...
ASAIO transactions 37 (4), 598-604, 1991
3921991
Glucose handling by the kidney
A Mather, C Pollock
Kidney international 79, S1-S6, 2011
3122011
Effects of SGLT2 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy?
U Panchapakesan, K Pegg, S Gross, MG Komala, H Mudaliar, J Forbes, ...
PloS one 8 (2), e54442, 2013
2402013
Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis
ISPD Adequacy of Peritoneal Dialysis Working Group
Peritoneal Dialysis International 26 (5), 520-522, 2006
2342006
Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD
BA Cooper, EL Penne, LH Bartlett, CA Pollock
American Journal of Kidney Diseases 43 (1), 61-66, 2004
2022004
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
1952019
Validity of subjective global assessment as a nutritional marker in end-stage renal disease
BA Cooper, LH Bartlett, A Aslani, BJ Allen, LS Ibels, CA Pollock
American journal of kidney diseases 40 (1), 126-132, 2002
1902002
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference
IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ...
Kidney international 89 (1), 28-39, 2016
1832016
Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells
SC Jones, HJ Saunders, W Qi, CA Pollock
Diabetologia 42 (9), 1113-1119, 1999
1811999
Integrated actions of transforming growth factor-β1 and connective tissue growth factor in renal fibrosis
W Qi, S Twigg, X Chen, TS Polhill, P Poronnik, RE Gilbert, CA Pollock
American Journal of Physiology-Renal Physiology 288 (4), F800-F809, 2005
1772005
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristics
MJ Jardine, KW Mahaffey, B Neal, R Agarwal, GL Bakris, BM Brenner, ...
American journal of nephrology 46 (6), 462-472, 2017
1762017
Comparing different methods of assessing body composition in end-stage renal failure
BA Cooper, A Aslani, M Ryan, FYP Zhu, LS Ibels, BJ Allen, CA Pollock
Kidney international 58 (1), 408-416, 2000
1742000
Erythropoiesis‐stimulating agent hyporesponsiveness
DW Johnson, CA Pollock, IC Macdougall
Nephrology 12 (4), 321-330, 2007
1672007
The renal cortical fibroblast in renal tubulointerstitial fibrosis
W Qi, X Chen, P Poronnik, CA Pollock
The international journal of biochemistry & cell biology 38 (1), 1-5, 2006
1632006
Developing a set of core outcomes for trials in hemodialysis: an international Delphi survey
N Evangelidis, A Tong, B Manns, B Hemmelgarn, DC Wheeler, P Tugwell, ...
American Journal of Kidney Diseases 70 (4), 464-475, 2017
1602017
Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts
S Zafiriou, SR Stanners, S Saad, TS Polhill, P Poronnik, CA Pollock
Journal of the American Society of Nephrology 16 (3), 638-645, 2005
1562005
The system can't perform the operation now. Try again later.
Articles 1–20